Jason Douglas Wilson, Executive VP of Operations at REATA PHARMACEUTICALS INC (RETA), sold 11,680 shares at $200.17 ($2.4M) on 2019-12-16, disclosed to the SEC on 2019-12-17.
Open-market sale of $2.4M RETA by Executive VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.17 | 500 | $100K | 4.2% |
| 2 | $201.65 | 1,300 | $262K | 11.0% |
| 3 | $202.51 | 3,400 | $689K | 29.0% |
| 4 | $203.60 | 2,320 | $472K | 19.9% |
| 5 | $204.54 | 1,480 | $303K | 12.7% |
| 6 | $204.54 | 1,480 |
| $303K |
| 12.7% |
| 7 | $205.07 | 200 | $41K | 1.7% |
| 8 | $205.08 | 200 | $41K | 1.7% |
| 9 | $206.88 | 400 | $83K | 3.5% |
| 10 | $207.48 | 400 | $83K | 3.5% |
| Total | $203.45 avg | 11,680 | $2.4M | 100% |
| Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |
| RETA | SELL | 2019-06-19 | $668K | — | Filing → |